Pure Global

Synagosin I test reagent - Taiwan Registration 57adc3fbd6ff625c4e9b9acab2720777

Access comprehensive regulatory information for Synagosin I test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 57adc3fbd6ff625c4e9b9acab2720777 and manufactured by Quidel Cardiovascular Inc.. The authorized representative in Taiwan is BIO-CHECK LABORATORIES LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
57adc3fbd6ff625c4e9b9acab2720777
Registration Details
Taiwan FDA Registration: 57adc3fbd6ff625c4e9b9acab2720777
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Synagosin I test reagent
TW: ๅฟซๅพ—ๅˆฉ ๆฃ่€ถๆฟŸ ่‚Œ้ˆฃ่›‹็™ฝIๆชข้ฉ—่ฉฆๅŠ‘
Risk Class 2

Registration Details

57adc3fbd6ff625c4e9b9acab2720777

DHA05602840607

Company Information

United States

Product Details

This reagent was used by immunofluorescence analysis and Alere Triage MeterPro instrument to rapidly quantify the content of Troponin I in whole blood and plasma samples after EDTA anticoagulation.

A Clinical chemistry and clinical toxicology

A.1215 Creatine phosphokinase/creatine kinase or isoenzyme test system; A.1660 Quality control materials (analytical and non-analytical)

import

Dates and Status

Apr 19, 2016

Apr 19, 2026